Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
 |
2023 –2030 |
 |
USD 3.25 Billion |
 |
USD 5.00 Billion |
 |
% |
|
|
Global Non-ossifying Fibromas Market, By Treatment (Curettage, Cryotherapy, Bone Grafting, Others), Diagnosis (X-ray, Biopsy, Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI), Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Industry Trends and Forecast to 2030.
The increase in the incidence of non-ossifying fibroma and growing healthcare expenditure are the primary factors boosting the market growth rate. Non-ossifying fibromas are the most common benign bone tumors witnessed in children, affecting around 20-40%. No known cause, the genetic link, or risk factor is involved in the growth of a non-ossifying fibroma. Numerous manufacturers are assisting in developing numerous treatment processes to help the market grow.
Data Bridge Market Research analyses that the non-ossifying fibromas market, which was USD 3.25 billion in 2022, would rise up to USD 5 billion by 2030 and is expected to undergo a CAGR of 5.50% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Treatment (Curettage, Cryotherapy, Bone Grafting, Others), Diagnosis (X-ray, Biopsy, Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI), Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)
|
|
Countries Covered
|
U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Quantum Cryogenics (U.K.), BTG International Inc. (U.S.), CryoConcepts LP (U.S.)., Zimmer MedizinSysteme GmbH (Germany), Medtronic (Ireland), Cortex Technology (Denmark), CooperSurgical, Inc. (U.S.), AtriCure, Inc (U.S.)., Hologic, Inc. (U.S)., PHYSIOMED AG (Germany), BOWA MEDICAL (Germany), Prima Medical (U.K.), XcelLance Medical Technologies Pvt. Ltd.(India), Smith+Nephew (U.K.)
|
|
Market Opportunities
|
|
Market Definition
Non-ossifying fibromas (NOF) is a type of benign tumor, a collection of abnormal cells that do not spread to other body parts. These fibromas are more prevalent in men than in women, and they are often discovered after an x-ray of the area is taken for another reason, such as pain after a fall. Several children suffering from NOFs have no symptoms, and these benign tumors typically vanish without therapy.
Drivers
The increasing incidence of this fibroma is expected to enhance market growth. It is predicted that NOF may be present in up to 30% of children. Non-ossifying fibromas are prevalent in children and adolescents and are considered the most common benign tumor. It has been witnessed that non-ossifying fibroma is one of the most common benign fibrous bone lesions, with an average prevalence of 30-40% globally in 2021, particularly in males, between the age group of 2 and 20 years. Thus, this factor leads to the growth of the market.
There are varied diagnostic measures associated with NOF that lead to market growth. The diagnosis of non-ossifying fibromas is primarily based on characteristic radiographic or imaging features. X-rays are generally sufficient to detect a non-ossifying fibroma and to identify its growth from time to time. If the tumor is comparatively large, healthcare professionals may require a detailed imaging test, such as an MRI or CT scan, to look closely at the bone and check for signs of weakening. Thus, this factor help in the market growth.
Opportunities
There is a huge growth of treatment processes that increases the market growth. Non-ossifying fibromas are removed through a surgical procedure known as curettage. If they are large, as in involving >50% of the diameter of the parent bone, then prophylactic curettage and bone grafting may be necessary to avoid a pathological fracture. A bone graft may be taken from a donor or another bone in the body. Thus, this factor boosts market growth.
Restraints/Challenges
The treatment of NOF is much higher in cost, leading to market hindrance. The surgical treatment methods, including curettage and bone grafting, lead to very high costs, which many patients cannot afford in the economic section. Thus, the increasing cost of treatment and drugs is anticipated to impede market growth during the forecast period.
This non-ossifying fibromas market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the non-ossifying fibromas market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
The non-ossifying fibromas market is segmented on the basis of treatment, diagnosis, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Treatment
Diagnosis
End-User
Distribution Channel
The non-ossifying fibromas market is analyzed and market size insights and trends are provided by treatment, diagnosis, end-users and distribution channel as referenced above.
The countries covered in the non-ossifying fibromas market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Asia-Pacific is expected to grow during the forecast period of the non-ossifying fibromas market because of the growing research and development activities and rising investment in the healthcare sector. Also, increasing government support for its treatment and diagnostic methods leads to the enhancement of the market.
North America dominates the market in the forecast period due to the wide presence of major market players and high disposable income. Also, well-developed healthcare infrastructure in this region leads to market growth.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The non-ossifying fibromas market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for non-ossifying fibromas market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the non-ossifying fibromas market. The data is available for historic period 2011-2021.
The non-ossifying fibromas market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to non-ossifying fibromas market.
Some of the major players operating in the non-ossifying fibromas market are:
SKU-
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
The market is segmented based on Global Non-ossifying Fibromas Market, By Treatment (Curettage, Cryotherapy, Bone Grafting, Others), Diagnosis (X-ray, Biopsy, Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI), Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Industry Trends and Forecast to 2030. .
The Global Non Ossifying Fibromas Market size was valued at USD 3.25 USD Billion in 2022.
The Global Non Ossifying Fibromas Market is projected to grow at a CAGR of 5.5% during the forecast period of 2023 to 2030.
The major players operating in the market include Quantum Cryogenics , BTG International Inc. , CryoConcepts LP ., Zimmer MedizinSysteme GmbH , Medtronic Cortex Technology CooperSurgicalInc. , AtriCureInc ., HologicInc. ., PHYSIOMED AG , BOWA MEDICAL , Prima Medical , XcelLance Medical Technologies Pvt. Ltd., Smith+Nephew .
The market report covers data from the U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
